Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Translate bio, inc. symbols : SNY save search
Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors
Published: 2023-08-02 (Crawled : 20:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.11%
C: 0.11%
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -3.79%
H: 0.0%
C: 0.0%
KRYS | News | $162.175 3.13% 3.04% 220K
|
Health Technology
|
| O: -2.31%
H: 0.73%
C: -1.14%
EQ | $1.77 7.27% 6.78% 88K
|
Health Technology
|
| O: 9.59%
H: 7.68%
C: -6.75%
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: 0.02%
H: 0.26%
C: 0.22%
ALLK | $1.055 -0.47% -0.47% 270K
|
Health Technology
|
| O: -0.91%
H: 1.84%
C: -1.1%
DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
Published: 2022-11-01 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -4.49%
H: 3.81%
C: 1.95%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
CVAC | $2.585 2.17% 2.13% 610K
|
Health Technology
|
| O: 1.1%
H: 3.4%
C: -1.36%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
|
| O: 1.06%
H: 2.53%
C: 1.75%
space pharma companies set
BioSpace Movers & Shakers, Feb. 11
Published: 2022-02-11 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
RARE F | $45.06 3.14% 3.04% 840K
|
Health Technology
|
| O: 6.19%
H: 0.0%
C: 0.0%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: -1.12%
H: 0.0%
C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: -1.72%
H: 0.0%
C: 0.0%
CDXS | $2.895 1.22% 1.21% 190K
|
Process Industries
|
| O: 0.2%
H: 0.0%
C: 0.0%
CLSD | News P | $1.36 -3.55% -3.68% 230K
|
Health Technology
|
| O: 1.46%
H: 0.0%
C: 0.0%
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: -2.54%
H: 0.0%
C: 0.0%
space spac
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-09-08 (Crawled : 21:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: -0.13%
H: 0.67%
C: -0.05%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.54%
H: 0.23%
C: -0.59%
granted grant
Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-05 (Crawled : 22:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.0%
H: 0.34%
C: -0.03%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
financial results results
Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development
Published: 2021-08-03 (Crawled : 06:00) - globenewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 0.54%
H: 0.29%
C: -0.16%
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 29.16%
H: 0.21%
C: 0.05%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.31%
H: 0.22%
C: 0.12%
vaccine technology
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-07-07 (Crawled : 21:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: -2.1%
H: 4.93%
C: 4.21%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.16%
H: 0.18%
C: 0.08%
granted grant
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
Published: 2021-06-22 (Crawled : 06:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.0%
H: 10.57%
C: 10.25%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.57%
H: 0.25%
C: -0.04%
phase 1 vaccine influenza trial phase 2 phase 3
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-06-09 (Crawled : 21:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.65%
H: 2.56%
C: -0.64%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.21%
H: 1.07%
C: 0.67%
granted grant
Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
Published: 2021-06-07 (Crawled : 12:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.48%
H: 4.45%
C: 2.41%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.85%
C: -0.06%
vaccine influenza milestone
Translate Bio to Participate in Upcoming Investor Conferences
Published: 2021-05-24 (Crawled : 12:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 1.2%
H: 0.28%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.02%
H: 0.3%
C: -0.3%
conference
Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference
Published: 2021-05-18 (Crawled : 14:15) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.0%
H: 6.94%
C: 3.41%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -0.26%
results skin conference preclinical pre-clinical
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-05-05 (Crawled : 21:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: -3.57%
H: 0.0%
C: -11.06%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.51%
C: 0.29%
granted grant
Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit
Published: 2021-04-28 (Crawled : 12:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.14%
H: 6.13%
C: 6.09%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.86%
H: 0.89%
C: 0.11%
life science
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-04-20 (Crawled : 21:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: -1.11%
H: 4.96%
C: 4.91%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.48%
H: 0.59%
C: 0.4%
granted grant
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
Published: 2021-04-19 (Crawled : 12:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.37%
H: 2.17%
C: 1.69%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.15%
C: -0.04%
covid results vaccine preclinical pre-clinical
Translate Bio Announces Key Leadership Additions and Promotions
Published: 2021-04-19 (Crawled : 12:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.37%
H: 2.17%
C: 1.69%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.15%
C: -0.04%
Translate Bio Appoints Dr. Rand Sutherland as President
Published: 2021-03-22 (Crawled : 12:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 1.88%
H: 4.95%
C: -2.33%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.64%
H: 1.2%
C: 0.39%
Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
Published: 2021-03-17 (Crawled : 21:00) - biospace.com/
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: -0.52%
H: 3.54%
C: 3.25%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: -0.14%
ongoing fibrosis phase 1 results trial phase 3 phase 2 cystic fibrosis
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
Published: 2021-03-12 (Crawled : 07:00) - globenewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 4.53%
H: 0.91%
C: -2.26%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid phase 1 vaccine trial phase 3 phase 2 covid-19
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.